niacinamide has been researched along with Coronary Vasospasm in 20 studies
nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.
Coronary Vasospasm: Spasm of the large- or medium-sized coronary arteries.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Sorafenib is a multikinase inhibitor that targets signaling pathways necessary for cellular proliferation and survival." | 5.35 | Sorafenib-induced acute myocardial infarction due to coronary artery spasm. ( Arima, Y; Fukushima, H; Nakamura, S; Noda, K; Ogawa, H; Oshima, S; Shono, M; Taniguchi, I, 2009) |
| "Nicorandil has the capacity to increase myocardial oxygen supply without increasing oxygen demand by reduction in preload and afterload." | 2.38 | Nicorandil: animal pharmacology. ( Sakai, K, 1989) |
| "Sorafenib is a multikinase inhibitor that targets signaling pathways necessary for cellular proliferation and survival." | 1.35 | Sorafenib-induced acute myocardial infarction due to coronary artery spasm. ( Arima, Y; Fukushima, H; Nakamura, S; Noda, K; Ogawa, H; Oshima, S; Shono, M; Taniguchi, I, 2009) |
| "Nicorandil was thus considered to produce its antianginal effect primarily by redistribution of coronary blood flow as a result of dilatation of vascular beds and by its antispasmodic action." | 1.27 | Effects of nicorandil on coronary circulation in patients with ischemic heart disease: comparison with nitroglycerin. ( Aizawa, T; Kato, K; Ogasawara, K, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (50.00) | 18.7374 |
| 1990's | 8 (40.00) | 18.2507 |
| 2000's | 1 (5.00) | 29.6817 |
| 2010's | 1 (5.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arima, Y | 1 |
| Oshima, S | 1 |
| Noda, K | 1 |
| Fukushima, H | 1 |
| Taniguchi, I | 1 |
| Nakamura, S | 1 |
| Shono, M | 1 |
| Ogawa, H | 1 |
| Naib, T | 1 |
| Steingart, RM | 1 |
| Chen, CL | 1 |
| Sakai, K | 3 |
| Akima, M | 2 |
| Shiraki, Y | 1 |
| Hoshino, E | 1 |
| Satoh, K | 1 |
| Maruyama, M | 1 |
| Yamashita, S | 1 |
| Taira, N | 2 |
| Kaski, JC | 1 |
| Takahashi, T | 1 |
| Fukai, T | 1 |
| Hata, H | 1 |
| Kasuya, H | 1 |
| Kuga, T | 1 |
| Egashira, K | 1 |
| Takeshita, A | 1 |
| Lablanche, JM | 2 |
| Bauters, C | 2 |
| McFadden, EP | 1 |
| Quandalle, P | 1 |
| Bertrand, ME | 2 |
| Hirose, Y | 1 |
| Gamo, M | 1 |
| Hirose, M | 1 |
| Harigae, M | 1 |
| Fujiwara, C | 1 |
| Leroy, F | 1 |
| Imagawa, J | 1 |
| Nabata, H | 1 |
| Kanemoto, N | 1 |
| Kawai, K | 1 |
| Hosokawa, J | 1 |
| Tagawa, R | 1 |
| Goto, Y | 1 |
| Kamijo, T | 1 |
| Tomaru, T | 2 |
| Miwa, A | 1 |
| Nakamura, F | 3 |
| Kido, H | 1 |
| Sugimoto, T | 2 |
| Uchida, Y | 3 |
| Sumino, S | 1 |
| Kato, A | 1 |
| Aizawa, T | 2 |
| Ogasawara, K | 2 |
| Kato, K | 2 |
| Hirosaka, A | 1 |
| Sakuma, T | 1 |
| Nagashima, K | 1 |
| Ohde, H | 1 |
| Morimoto, K | 1 |
| Kitao, T | 1 |
| Terada, K | 1 |
| Kohara, H | 1 |
| Tai, H | 1 |
| Fujimoto, M | 1 |
| Ogihara, T | 1 |
| Kumahara, Y | 1 |
| Kuromaru, O | 1 |
| Leitold, M | 1 |
| Hader, S | 1 |
3 reviews available for niacinamide and Coronary Vasospasm
| Article | Year |
|---|---|
Management of vasospastic angina--role of nicorandil.
Topics: Angina Pectoris; Anti-Arrhythmia Agents; Coronary Vasospasm; Humans; Niacinamide; Nicorandil | 1995 |
Potassium channel activators in vasospastic angina.
Topics: Angina Pectoris, Variant; Animals; Coronary Angiography; Coronary Circulation; Coronary Vasospasm; H | 1993 |
Nicorandil: animal pharmacology.
Topics: Angina Pectoris; Animals; Coronary Vasospasm; Dogs; Drug Tolerance; Niacinamide; Nicorandil; Vasodil | 1989 |
2 trials available for niacinamide and Coronary Vasospasm
| Article | Year |
|---|---|
[Prophylactic effect of nicorandil on perioperative coronary spasm].
Topics: Coronary Artery Bypass; Coronary Vasospasm; Elective Surgical Procedures; Humans; Niacinamide; Nicor | 1998 |
Prevention of coronary spasm by nicorandil: comparison with nifedipine.
Topics: Administration, Oral; Adult; Coronary Vasospasm; Double-Blind Method; Ergonovine; Humans; Middle Age | 1992 |
15 other studies available for niacinamide and Coronary Vasospasm
| Article | Year |
|---|---|
Sorafenib-induced acute myocardial infarction due to coronary artery spasm.
Topics: Aged; Antineoplastic Agents; Benzenesulfonates; Carcinoma, Renal Cell; Coronary Vasospasm; Humans; K | 2009 |
Sorafenib-associated multivessel coronary artery vasospasm.
Topics: Antineoplastic Agents; Benzenesulfonates; Coronary Vasospasm; Electrocardiography; Humans; Male; Mid | 2011 |
Effects of a new antianginal agent, nicorandil, on the cardiovascular system of the miniature pig: with special reference to coronary vasospasm.
Topics: Animals; Blood Pressure; Cardiovascular System; Coronary Circulation; Coronary Vasospasm; Dipyridamo | 1983 |
Nicorandil releases acetylcholine-induced sustained coronary arterial constriction in monkeys and baboons.
Topics: Acetylcholine; Animals; Coronary Circulation; Coronary Vasospasm; Disease Models, Animal; Dose-Respo | 1984 |
Effects of a new calcium antagonist, CD-832, on experimental coronary artery spasm in miniature pigs.
Topics: Animals; Calcium Channel Blockers; Coronary Vasospasm; Disease Models, Animal; Histamine; Infusions, | 1993 |
Spasmolytic action of nicorandil in canine conductive coronary arteries in vivo is not modified by glibenclamide.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Angiocardiography; Animals; Benz | 1992 |
Intermittent anterior divisional block and far advanced right bundle branch block induced by vasospasm during exercise testing.
Topics: Aged; Bundle-Branch Block; Coronary Vasospasm; Electrocardiography; Exercise Test; Heart Block; Huma | 1992 |
[The vasospasmolytic effects of nicorandil, cromakalim and pinacidil on 3,4-diaminopyridine-induced phasic contractions in canine coronary arteries as an experimental vasospasm model].
Topics: 4-Aminopyridine; Amifampridine; Animals; Benzopyrans; Coronary Vasospasm; Cromakalim; Disease Models | 1992 |
Phasic contractions of canine and human coronary arteries induced by potassium channel blockers.
Topics: 4-Aminopyridine; Adult; Aged; Amifampridine; Aminopyridines; Angina Pectoris, Variant; Animals; Arte | 1986 |
Effects of nicorandil on coronary circulation in patients with ischemic heart disease: comparison with nitroglycerin.
Topics: Coronary Circulation; Coronary Disease; Coronary Vasospasm; Female; Hemodynamics; Humans; Male; Midd | 1987 |
Effect of nicorandil on coronary spasm.
Topics: Adult; Coronary Vasospasm; Ergonovine; Female; Humans; Male; Middle Aged; Niacinamide; Nicorandil; V | 1989 |
Effects of the kallikrein-kinin system on phasic coronary vasospasm in dogs.
Topics: Animals; Bradykinin; Coronary Vasospasm; Coronary Vessels; Diltiazem; Dogs; Female; In Vitro Techniq | 1989 |
Effects of nicorandil on the rhythmic contractile response of isolated miniature pig coronary artery to 3,4-diaminopyridine: comparison with nitroglycerin.
Topics: 4-Aminopyridine; Amifampridine; Aminopyridines; Animals; Coronary Vasospasm; Coronary Vessels; Femal | 1986 |
[Influence of antianginal drugs on Lypressin induced T-wave enhancement in the electrocardiogram of the rat].
Topics: Administration, Oral; Angina Pectoris; Animals; Coronary Vasospasm; Electrocardiography; Hypoxia; Is | 1986 |
Decreasing potassium conductance--a possible mechanism of phasic coronary vasospasm.
Topics: 4-Aminopyridine; Amifampridine; Aminopyridines; Animals; Calcium; Coronary Vasospasm; Coronary Vesse | 1985 |